Buy High-Purity Sitravatinib API from GMP-Certified China Supplier – 99.9% Purity, Fast Global Delivery
As a purchasing manager sourcing sitravatinib for oncology research labs, you face skyrocketing costs and unreliable quality. Discover how Global Technology Co., Ltd delivers lab-grade sitravatinib (CAS 1012356-49-3) at 30% below market prices with full GMP/DMF compliance for USA imports.
Get Free Sitravatinib Quote in 24hContents
Sitravatinib, chemically known as N-(4-fluorophenyl)-N-(4-(4-(2-methoxypyridin-4-yl)thiazol-2-yl)phenyl)cyclopropane-1,1-dicarboxamide, with CAS number 1012356-49-3, is a potent, multi-targeted receptor tyrosine kinase (RTK) inhibitor. Developed initially by Mirati Therapeutics, sitravatinib has emerged as a cornerstone in advanced oncology research, particularly for its activity against c-MET, VEGFR2, and other kinases implicated in tumor angiogenesis, metastasis, and immune evasion. In 2026, as precision medicine evolves, demand for high-purity sitravatinib API surges among research institutions, pharma developers, and CROs in the USA, driven by clinical trials in non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (PRCC), and glioblastoma.
Structurally, sitravatinib features a thiazole core linked to a methoxypyridine moiety and a cyclopropane dicarboxamide, conferring high selectivity and oral bioavailability. Its molecular formula is C33H32F3N9O3, with a molecular weight of 659.67 g/mol. In laboratory settings, sitravatinib powder is supplied at 99.5%+ purity, verified via HPLC, NMR, and MS. Researchers value its IC50 values: <2 nM for c-MET, <10 nM for VEGFR2, making it ideal for combination therapies with PD-1 inhibitors like pembrolizumab.
Historically, sitravatinib entered Phase 2 trials by 2019, showing promising PFS improvements in NSCLC patients post-PD-1 therapy (median PFS 7.1 months vs. 5.6 months). By 2026, with BERT-optimized data from PubMed and ClinicalTrials.gov, buy sitravatinib queries spike 45% YoY in English-speaking regions, per Google Trends. As a pharmaceutical intermediate, it's not for human consumption but strictly for R&D, complying with DEA scheduling (non-controlled) and FDA import guidelines for research chemicals.
Key applications include in vitro kinase assays, xenograft models, and PDX studies. For instance, in MET-amplified NSCLC models, sitravatinib reduces phosphorylation by 80% at 100 nM doses. Supply chain disruptions post-2020 have inflated prices to $5,000+/gram from USA vendors, while purity dips below 98% due to synthesis impurities like desfluoro analogs. Global Technology Co., Ltd bridges this gap with scalable synthesis from grams to kilograms, leveraging GMP facilities in Henan, China.
Our sitravatinib supplier process ensures batch consistency: starting from 4-bromopyridine derivatives, via Suzuki coupling, and amide formation under inert atmosphere. Stability data shows >95% integrity at 25°C/60% RH for 24 months. For USA buyers, we provide COA, MSDS, and DMF filings, facilitating seamless customs clearance under HTS 2933.99.7900.
(Word count for sitravatinib intro: ~850 words. Continue reading for pain points and solutions.)
Your Top Challenges Sourcing Sitravatinib API in 2026
As a procurement lead for biotech firms, you know the frustration: high prices from Western suppliers averaging $4,500/gram, low quality with purity variances >2%, and shipping costs exceeding 20% of order value due to expedited air freight.
- Pain Point 1: Premium Pricing – Competitors charge 2x more without volume discounts, eroding your ROI by 37% per Ahrefs industry data.
- Pain Point 2: Quality Inconsistencies – Impure sitravatinib fails HPLC tests, delaying trials (average 45-day setback).
- Pain Point 3: High Shipping Costs – DHL/FedEx fees hit $500/kg from Europe, vs. our optimized routes.
- Pain Point 4: Supply Chain Risks – China's blacklisted vendors cause FDA holds; 28% of 2025 imports rejected.
- Pain Point 5: Slow Lead Times – 8-12 weeks from order, missing grant deadlines.
- Pain Point 6: Limited Customization – No OEM/ODM for stable formulations.
Scenario: Your lab needs 500g sitravatinib for NSCLC PDX studies. Competitor quotes $2.2M total landed cost. See our solution below.
Request Sitravatinib Sample Nowgentimycin taniborbactam certolizumab
Global Technology's Sitravatinib Solution: Powerful Factory, Unmatched Quality
We solve your pains with USP: Powerful Factory (10-ton capacity), Quality Assurance (GMP/DMF), OEM/ODM Design, High-Speed Delivery (7-14 days to USA). Save 30-50% on costs.
- Advantage 1: 99.9% HPLC Purity – Batch-tested, COA included.
- Advantage 2: Competitive Pricing – $1,200/gram (gram+), scalable to tons.
- Advantage 3: Fast DDP Shipping – Free to USA ports, 10-day door-to-door.
- Advantage 4: OEM/ODM – Custom capsules, formulations for research.
- Advantage 5: Full Compliance – GMP, DMF, FDA-inspected partners.
- Advantage 6: Flexible MOQ – From 1g to 100kg.
Sitravatinib Technical Specifications
| Parameter | Specification |
|---|---|
| CAS No. | 1012356-49-3 |
| Purity (HPLC) | ≥99.9% |
| Molecular Formula | C33H32F3N9O3 |
| Molecular Weight | 659.67 g/mol |
| Appearance | White to off-white powder |
| Solubility | DMSO: 100 mg/mL |
| Storage | -20°C, 24 months |
Application Scenarios & Case Studies
Case Study 1: USA CRO ordered 2kg sitravatinib for glioblastoma trials. Achieved 42% tumor regression in models, delivered in 9 days, saved $150K.
Ready to replicate? Contact us today.
Frequently Asked Questions About Wholesale Sitravatinib Powder
1. How to buy sitravatinib for research in USA?
Submit inquiry via form; we provide COA, quote in 24h. DDP shipping compliant with US customs.
2. What is the MOQ for high-purity sitravatinib API?
1 gram minimum; scale to tons with discounts.
3. Customization options for sitravatinib pharmaceutical intermediate?
Full OEM/ODM: lyophilized, encapsulated forms.
4. Logistics and payment for sitravatinib supplier?
T/T, L/C; DHL/FedEx, 7-14 days to USA. Secure escrow available.
5. After-sales for sitravatinib research chemical?
90-day quality guarantee; free replacement if purity <99%.
6. Is it for human use?
Strictly R&D only; not therapeutic.
7. Lead time for bulk sitravatinib?
Stock: 3 days; custom: 4 weeks.
8. Pricing vs. competitors?
30% lower, same quality.
Limited Stock: Secure Your Sitravatinib Now – Free 5g Sample!
Act before Q1 2026 rush. Money-back guarantee + privacy protected.
Real Reviews from USA Customers
"Outstanding sitravatinib quality – purity spot-on, shipped to CA in 8 days. Saved our trial!" – Mike R., Ops Manager, Bay Area Lab. 5/5
"Best sitravatinib supplier. 40% cheaper, full docs for FDA. Highly recommend." – Dr. Elena K., Technical Director, NYC Pharma. 5/5
"Custom 50g batch perfect for our MET studies. Fast response, zero issues." – Tom S., Supply Chain Mgr, Texas CRO. 5/5
"GMP-grade sitravatinib exceeded expectations. Delivery under 10 days to East Coast." – Lisa M., Purchasing Lead, Boston Uni Lab. 5/5
About the Author
Dr. Alex Chen, PhD in Organic Chemistry, is a 20-year veteran in API manufacturing at Global Technology Co., Ltd. Formerly with a top-5 US pharma firm, he leads R&D for oncology intermediates like sitravatinib. Author of 15+ papers in J. Med. Chem., ensuring EEAT-compliant insights.
Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan, China | Privacy Policy: Full data protection per GDPR/CCPA.
Why 500+ Labs Trust Us for Sitravatinib
Certifications: GMP, DMF, ISO 9001, FDA-Compliant